First Scientific Study of an Ape
English anatomist Edward Tyson dissects a chimpanzee — the first scientific study of a true ape specimen. His work is housed at the Natural History Museum in London to this day.
Three centuries of discovery, regulation, ethical reckoning, and an industry in transformation.
The global research enterprise has depended on a handful of source countries — India (until 1978), then China (until 2020) — creating repeated crises when export bans are imposed for political, ethical, or public health reasons.
Two decades of sustained campaigning has resulted in most major airlines refusing to transport research primates. Airline participation has largely ended, forcing reliance on charter and specialized transport.
From the UK's 1997 great ape ban to the EU's 2010 Directive and the U.S.'s 2015 end of chimpanzee research, governments have progressively restricted the most controversial forms of primate experimentation.
The 2022 FDA Modernization Act removed the legal requirement for animal testing in drug development. Organ-on-chip, computational biology, and AI modeling are increasingly positioned as replacements — though the transition remains contested.
The 2022 IUCN uplisting of long-tailed macaques to "Endangered" has placed the biomedical research industry and conservation advocates on a collision course, with billions of dollars of research depending on a species in steep decline.
English anatomist Edward Tyson dissects a chimpanzee — the first scientific study of a true ape specimen. His work is housed at the Natural History Museum in London to this day.
Charles Darwin publishes On the Origin of Species, igniting lasting scientific interest in the relationship between humans and other primates.
Karl Landsteiner and Erwin Popper inject filtered spinal cord fluid from a human polio victim into monkeys, inducing the disease and proving polio is caused by a virus. This launches decades of primate-dependent polio research.
Early nerve-tissue vaccine experiments resulted in severe adverse outcomes, halting progress and setting development back for years.
John Enders and colleagues show poliovirus can be grown in human tissue culture — verified by injection into monkeys. This Nobel Prize–winning breakthrough paves the way for the Salk and Sabin vaccines.
Jonas Salk develops his inactivated polio vaccine using minced rhesus macaque kidney cells. Hundreds of thousands of monkeys are imported from India; an estimated 15–20% die shortly after arrival. Between 1955 and 1963, ~98 million Americans are exposed to vaccines later found to contain SV40 (Simian Virus 40), a monkey virus whose long-term human health impact remains debated.
Congress authorizes eight NIH Regional Primate Research Centers, formalizing large-scale primate research infrastructure and systematic federal funding.
Jane Goodall starts her field study of wild chimpanzees at Gombe Stream, Tanzania — eventually producing over 300 publications and reshaping our understanding of primate cognition.
The first U.S. federal law regulating the treatment of animals in research. Covers dogs, cats, non-human primates, and other species used in research, exhibition, or the pet trade.
Science publishes "Teaching Sign Language to a Chimpanzee." Evidence that chimps can acquire and use human language intensifies ethical arguments against invasive research.
The U.S. Endangered Species Act and the international CITES treaty are both established, creating frameworks for protecting wildlife — including primates — from overexploitation and trade.
India — the world's largest exporter of monkeys — bans rhesus macaque exports after revelations of military use, alongside growing animal welfare pressure, conservation concerns, and geopolitical tensions. Exports had fallen from ~50,000/year to ~12,000/year. The ban causes a seismic shift, pushing researchers toward long-tailed macaques from Southeast Asia.
The Improved Standards for Laboratory Animals Act amends the AWA, requiring environmental enrichment and standards for the psychological well-being of primates in research.
Animal rights campaigns in the UK begin targeting airports and airlines that transport lab-bound primates — launching a two-decade campaign to sever supply lines.
The Great Ape Project is founded, arguing that chimpanzees, bonobos, gorillas, and orangutans deserve limited legal personhood — the right to life, liberty, and freedom from torture.
The United Kingdom announces it will no longer grant licenses for research on great apes — the first country in the world to formally restrict primate use at this level. The Home Secretary declares: "This is a matter of morality."
New Zealand (2000) becomes the first to legislate a ban. The Netherlands (2002), Sweden (2003), Austria (2006), and Japan (2006) follow suit. The U.S. CHIMP Act (2000) establishes a federal sanctuary system.
British Airways announces it will no longer carry animals bound for scientific experimentation — a major early airline exit that sets a precedent for the industry.
The European Union formally bans the use of great apes in research, restricts other NHP use, bans wild-caught monkeys, and mandates the 3Rs principle (Replacement, Reduction, Refinement). Takes effect across 27 member states in January 2013.
The Institute of Medicine concludes that "most current use of chimpanzees for biomedical research is unnecessary." NIH Director Francis Collins immediately halts new chimp research funding — a watershed moment.
The three largest global cargo carriers confirm policies restricting transport of mammals destined for laboratory research, further constricting supply chains.
NIH announces it will significantly reduce chimpanzee use, retiring ~310 federally owned chimps while retaining a "reserve" of 50 for potential future need.
Following a year of sustained PETA campaigning, United Airlines bans transporting primates to laboratories, citing animal rights pressure and passenger safety concerns.
The U.S. Fish and Wildlife Service ends the unusual "split listing," giving captive chimps the same "endangered" status as wild chimps. Federal permits now required for any work likely to cause harm.
NIH Director Francis Collins announces NIH will no longer support any biomedical research on chimpanzees. The remaining 50 "reserve" chimps are declared eligible for sanctuary retirement. The U.S. becomes one of the last major biomedical research nations to cease invasive chimpanzee research.
American Airlines, Delta, Southwest, Lufthansa, Virgin Atlantic, Air Canada, Qantas, South African Airways, and many others have adopted policies against transporting research primates — forcing reliance on charter and specialized transport. Only a handful of holdouts remain.
Russian carrier AirBridgeCargo, one of the last major holdout cargo airlines, stops transporting NHPs after a PETA campaign generates 200,000 emails.
The biomedical research lobby files a complaint alleging airlines "illegally discriminate" by refusing lab animal shipments. Airlines call it "misguided" and "far-fetched." Over 20,000 public comments favor the bans. DOT takes no action.
Following COVID-19's emergence, China halted exports from breeding colonies following wildlife trade restrictions, effectively freezing global supply. China had supplied 60–80% of U.S. NHP imports. A global shortage begins just as vaccine research demand skyrockets.
The price of a single long-tailed macaque rises from $2,000–$6,000 to $20,000–$55,000+. NIH acknowledges insufficient NHPs exist for both pandemic and existing research. Industry reports described unborn animals being reserved in advance to secure future supply.
The IUCN uplists the long-tailed macaque from "Vulnerable" to "Endangered," citing trade for biomedical research as a major threat. The species has experienced an estimated ~80% population decline over recent decades.
Air France, which had long defended primate transport as supporting biomedical science, reverses course and announces it will stop carrying primates for experimentation. Airline participation has largely ended, forcing reliance on charter and specialized transport.
The U.S. Department of Justice indicts 8 individuals — including Cambodian officials — for laundering wild-caught macaques as captive-bred. Exports surged rapidly as Cambodia moved to fill the supply gap left by China, with its export business growing from $34M to $253M in three years. Charles River Laboratories is also investigated.
President Biden signs legislation removing the 84-year-old mandate requiring animal testing for new drug development. The FDA can now accept organ-on-chip, cell-based, and computational alternatives. A legal watershed — though it doesn't ban animal testing outright.
Following the smuggling indictments, Cambodian long-tailed macaque imports to the U.S. plummet from 17,992 in 2022 to just 189 in 2023. The National Academies conclude the U.S. must expand domestic primate breeding.
Philippine Airlines announces it will not transport "any and all types of primates destined for cruel research and experimentation" — a carrier that had been a primary route for monkeys from Indonesia and the Philippines.
The FDA commits to accelerating adoption of New Alternative Methods (NAMs): organ-on-chip systems, human organoids, microphysiological systems, and AI computational models.
After years of lobbying by NABR to reverse the classification, the IUCN concludes the scientific evidence supports severe and ongoing global population decline of long-tailed macaques. The "Endangered" designation stands.
CDC signals reductions and reassessment of primate research programs amid a broader federal shift toward non-animal testing. Combined with the FDA Modernization Act, this reflects what may be a paradigm change in U.S. biomedical research policy.